Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
Early Arthritis Insights from the CATCH Cohort
Louis Bessette MD, FRCP(C), MSc
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
Key Advances in Rheumatology at CCR East 2026
The Next Era of Psoriatic Arthritis Management
Laura Coates, MBChB, MRCP, PhD
Aligning Patient and Physician Perspectives in Psoriatic Arthritis
Modern Approaches to Psoriatic Arthritis Management
Lawrence H. Brent
Diagnosing Psoriatic Arthritis: A Real-World Case
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
Flavia Castelino, MD
Benjamin Korman, MD
Navigating the Modern PsA Treatment Landscape
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD
Marc Scherlinger, MD, PhD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.